Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




System Simultaneously Quantifies mRNA, microRNA, and DNA

By LabMedica International staff writers
Posted on 31 Aug 2011
A multiplex polymerase chain reaction (PCR) platform simultaneously detects and quantifies disparate target types, such as mRNA, miRNA, single nucleotide polymorphisms (SNPs), and DNA.

Called ICEPlex, the open platform will enable clinical labs to develop cost-effective, high impact molecular diagnostic tests easily. More...
ICEPlex is an automated high throughput, high multiplex, molecular testing system based on Scalable Target Amplification Routine (STAR) technology. A stand-alone bench-top analyzer, it is capable of running up to 96 samples (including controls) and reporting on up to 60 targets in each in less than four hrs.

Because of the high level of multiplex enabled by STAR, multiple standards and calibrants are included in each sample along with primers for the intended targets. These are employed to enable reliable and sensitive detection of targets and accurate quantitative determinations of target load.

PrimeraDx (Mansfield, MA, USA) launched the ICEPlex system, which allows users to take one slice of tissue, extract the nucleic acids, and in one well in parallel, look at mRNA expression, microRNA expression, and SNPs.

Andrew Schade, MD, PhD, senior director of Lilly Clinical Diagnostics Laboratory (Indianapolis, IN, USA) commented, “The ICEPlex system is already changing the way we approach assay development, allowing us to create innovative solutions that were previously not possible.”

Related Links:

PrimeraDx
Lilly Clinical Diagnostics Laboratory



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Gold Member
Automatic Hematology Analyzer
CF9600
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.